BDBM506241 (S)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1H- 1,2,3-triazol-4-yl)(2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)amino)-4- (neopentylamino)quinoline-3,8-dicarbonitrile::US11066414, Compound 891

SMILES Cn1ccc2c(cccc2c1=O)[C@H](Nc1cc(C#N)c2ncc(C#N)c(NCC(C)(C)C)c2c1)C1=CN(NN1)C12CC(C1)C2

InChI Key InChIKey=GERDXNGLQLPSLW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 506241   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM506241(US11066414, Compound 891 | (S)-6-(((1-(bicyclo[1.1...)
Affinity DataIC50: 1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
Go to US Patent